✦ LIBER ✦

Early clinical results with the new oral glycoprotein IIb/IIIa agents

✍ Scribed by Paul S Teirstein

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An overview of the results of clinical t

✍ A.A.Jennifer Adgey 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Difficulties with oral platelet glycopro

✍ Christopher Heeschen; Christian W Hamm 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 52 KB

Oral Glycoprotein IIb/IIIa Antagonists:

✍ Darren K. McGuire; L. Kristin Newby 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 168 KB

Economic evaluation of bivalirudin with

✍ David J. Cohen; A. Michael Lincoff; Tara A. Lavelle; Huei-Ling Chen; Ameet Bakha 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 130 KB

The Clinical Results of a Platelet Glyco

✍ Weon Kim; Myung Ho Jeong; Kye Hun Kim; Il Suk Sohn; Young Joon Hong; Hyung Wook 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Sustained platelet GP IIb/IIIa blockade

✍ J.J. Ferguson; P.C. Deedwania; D.J. Kereiakes; D. Fitzgerald; R.J. Anders; D.M. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 192 KB